The National Institutes of Health (NIH) is offering this grant to support vital research focusing on the genetic underpinnings of immune-mediated diseases. This grant is for defining associations between variations in human leukocyte antigen (HLA) and killer-cell immunoglobulin-like receptor (KIR) genetic regions and these diseases. It also aims to elucidate the intricate mechanisms driving these associations, with the ultimate goal of paving the way for innovative therapeutic opportunities. Additionally, the funding supports the validation of critical association data, which will significantly enhance the predictive power of clinical disease screening and diagnostics, improving patient outcomes.
Opportunity ID: 353708
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-017 |
| Funding Opportunity Title: | Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 23, 2024 |
| Last Updated Date: | Apr 23, 2024 |
| Original Closing Date for Applications: | Aug 20, 2024 |
| Current Closing Date for Applications: | Aug 20, 2024 |
| Archive Date: | Sep 25, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public and State controlled institutions of higher education City or township governments Small businesses Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-017.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353708 Full Announcement-RFA-AI-24-017 -> RFA-AI-24-017-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00285999 | Jul 20, 2024 | Aug 20, 2024 | View |
Package 1
Mandatory forms
353708 RR_SF424_5_0-5.0.pdf
353708 PHS398_CoverPageSupplement_5_0-5.0.pdf
353708 RR_OtherProjectInfo_1_4-1.4.pdf
353708 PerformanceSite_4_0-4.0.pdf
353708 RR_KeyPersonExpanded_4_0-4.0.pdf
353708 PHS398_ResearchPlan_5_0-5.0.pdf
353708 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353708 RR_Budget_3_0-3.0.pdf
353708 RR_SubawardBudget30_3_0-3.0.pdf
353708 PHS398_ModularBudget_1_2-1.2.pdf
353708 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
